Endovascular Therapy for Severe Cerebral Venous Sinus Thrombosis: Time is Vein?

التفاصيل البيبلوغرافية
العنوان:	Endovascular Therapy for Severe Cerebral Venous Sinus Thrombosis: Time is Vein?
المؤلفون:	Burns JD; Section of Neurocritical Care, Division of Neurology, Lahey Hospital & Medical Center, 41 Mall Rd., Burlington, MA, 01805, USA. Joseph.D.Burns@Lahey.org.; Department of Neurology, UMass Chan Medical School, Worcester, MA, USA. Joseph.D.Burns@Lahey.org., Orru E; Department of Radiology, Lahey Hospital & Medical Center, Burlington, MA, USA.; Department of Radiology, UMass Chan Medical School, Worcester, MA, USA.
المصدر:	Neurocritical care [Neurocrit Care] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.
Publication Model:	Ahead of Print
نوع المنشور:	Editorial
اللغة:	English
بيانات الدورية:	Publisher: Humana Press Country of Publication: United States NLM ID: 101156086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-0961 (Electronic) Linking ISSN: 15416933 NLM ISO Abbreviation: Neurocrit Care Subsets: MEDLINE
أسماء مطبوعة:	Original Publication: Totowa, NJ : Humana Press, c2004-
التعليقات:	Comment in: Neurocrit Care. 2024 Jul 23. doi: 10.1007/s12028-024-02046-7. (PMID: 39042279)
References:	Saposnik G, Bushnell C, Coutinho JM, Field TS, Furie KL, Galadanci N, et al. American heart association stroke council; council on cardiopulmonary, critical care, perioperative and resuscitation; council on cardiovascular and stroke nursing; and council on hypertension. diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. Stroke. 2024;55(3):e77-90. (PMID: 38284265) Klein P, Shu L, Nguyen TN, Siegler JE, Omran SS, Simpkins AN, et al. ACTION-CVT Study Group. Outcome prediction in cerebral venous thrombosis: the IN-REvASC score. J Stroke. 2022;24(3):404–16. (PMID: 10.5853/jos.2022.01606362219449561213) Bucke P, Henkes H, Kaesmacher J, Horvath T, Heldner MR, Scutelnic A, et al. Early versus late initiation of endovascular therapy in patients with severe cerebral venous sinus thrombosis. Neurocrit Care. 2024. https://doi.org/10.1007/s12028-024-02046-7 . (PMID: 10.1007/s12028-024-02046-7) Coutinho JM, Zuurbier SM, Bousser MG, Ji X, Canhão P, Roos YB, et al. TO-ACT investigators. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial. JAMA Neurol. 2020;77(8):966–73. (PMID: 10.1001/jamaneurol.2020.1022324211597235912) Park MG, Roh J, Ahn SH, Park KP, Baik SK. Papilledema and venous stasis in patients with cerebral venous and sinus thrombosis. BMC Neurol. 2023;23(1):175. (PMID: 10.1186/s12883-023-03228-03711867410148469) Sato T, Terasawa Y, Mitsumura H, Komatsu T, Sakuta K, Sakai K, et al. Venous stasis and cerebrovascular complications in cerebral venous sinus thrombosis. Eur Neurol. 2017;78(3–4):154–60. (PMID: 10.1159/00047898028848116) Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17(11):1016–24. (PMID: 10.1016/S1474-4422(18)30318-1303538606261373) Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664–70. (PMID: 10.1161/01.STR.0000117571.76197.2614976332)
تواريخ الأحداث:	Date Created: 20240723 Latest Revision: 20240724
رمز التحديث:	20240725
DOI:	10.1007/s12028-024-02045-8
PMID:	39042278
قاعدة البيانات:	MEDLINE

Find this article in full text from Springer Verlag.

Full Text Finder

الوصف
تدمد:	1556-0961
DOI:	10.1007/s12028-024-02045-8